• Lonza says in talks to buy Capsugel; deal could top $5bn

    Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.
  • Product News

    Lonza Announces the Availability of Its XS Microbial Expression Technology™ Portfolio to Customers Worldwide Under a Research Evaluation Agreement The new licensable XS Technology™ Portfolio includes licensing options for both E. coli and P. pastoris...